Drug search by name

Methylphenidate Extended-Release Oral-Disintegrating Tablets and Glaucoma

Result of checking the interaction of drug Methylphenidate Extended-Release Oral-Disintegrating Tablets and disease Glaucoma for safety when used together.

Check result:

Methylphenidate Extended-Release Oral-Disintegrating Tablets <> Glaucoma

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of most CNS stimulants is contraindicated in patients with glaucoma, as these agents exhibit sympathomimetic activity and may induce mydriasis provoking an increase in intraocular pressure.

References:

"Product Information. Focalin (dexmethylphenidate)." Mikart Inc, Atlanta, GA.
"Product Information. Ritalin (methylphenidate)." Novartis Pharmaceuticals, East Hanover, NJ.

Methylphenidate Extended-Release Oral-Disintegrating Tablets

Generic Name: methylphenidate

Brand Name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin SR, Daytrana, Methylin ER

Synonyms: Methylphenidate

What is Methylphenidate Extended-Release Oral-Disintegrating Tablets?